Offer - Urjas Oil for just ₹ 1 X
Mitotax 110 Injection is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Breast Cancer. Mitotax 110 Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Mitotax 110 Injection depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
While these are the most often observed Mitotax 110 Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Mitotax 110 Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Mitotax 110 Injection is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Mitotax 110 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Mitotax 110 Injection related warnings section.
Mitotax 110 Injection is contraindicated in people with pre-existing medical conditions like Liver Disease, Herpes, Heart Disease as it can result in adverse effects. Other conditions have been mentioned below in the Mitotax 110 Injection contraindications section.
Besides this, Mitotax 110 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Mitotax 110 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Mitotax 110 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Mitotax 110 Injection safe for pregnant women?
Mitotax should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Mitotax 110 Injection safe during breastfeeding?
Mitotax may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Mitotax 110 Injection on the Kidneys?
There are no side effects of Mitotax on the kidneys.
What is the effect of Mitotax 110 Injection on the Liver?
The liver can be affected by Mitotax. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Mitotax only after medical advice.
What is the effect of Mitotax 110 Injection on the Heart?
Mitotax may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Mitotax 110 Injection unless your doctor advises you to do so -
Is this Mitotax 110 Injection habit forming or addictive?
Forming a habit of Mitotax 110 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mitotax 110 Injection can make you feel drowsy.
Is it safe?
Yes, Mitotax 110 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Mitotax 110 Injection in mental disorders is not effective.
Interaction between Food and Mitotax 110 Injection
Taking Mitotax 110 Injection with food does not harm your health.
Interaction between Alcohol and Mitotax 110 Injection
Taking alcohol with Mitotax 110 Injection can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 967-969
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 865-866
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Taxol® (paclitaxel)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user;Abraxane® (paclitaxel protein-bound particles)